Another transporter, called ATP7A (ATPase Cu2+ transporting alpha polypeptide), is upregulated in in vitro models of resistant pancreatic tumors due to decreased expression of miR-374b (174) and increased ATP7A protein expression is at least partially responsible for cisplatin resistance in pancreatic cancer model systems (174). Here, ATP7A is linked to familial pancreatic carcinoma.